Anti-L3MBTL1 antibodies are used in the immunodetection of the protein L3MBTL histone methyl-lysine binding protein 1. In humans, the canonical protein has a reported length of 840 amino acid residues and a mass of 92.3 kDa. Its subcellular localization is in the nucleus. Up to 5 different isoforms have been reported for this protein. It is widely expressed across many tissue types. L3MBTL1 is known to be involved with chromatin organization and the regulation of transcription. Post-translational modifications have been described, including ubiquitination. Synonyms for this target antigen include L3MBTL, ZC2HC3, dJ138B7.3, lethal(3)malignant brain tumor-like protein 1, L3MBTL1, histone methyl-lysine binding protein, and H-L(3)MBT. L3MBTL1 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. A number of L3MBTL1 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. In addition, Immunofluorescence is also a common application.